National cancer institute selects icf for epidemiology and genetics research idiq

Company will compete for up to $320 million in research and clinical operations support services fairfax, va. , aug. 15, 2022 /prnewswire/ -- the national institutes of health (nih) national cancer institute's (nci) division of cancer epidemiology and genetics (dceg) recently selected global consulting and digital services provider icf (nasdaq:icfi) as one of five awardees for a new multiple-award indefinite delivery, indefinite quantity (idiq) contract to provide epidemiologic and clinical operations support for studies and other research activities.
ICFI Ratings Summary
ICFI Quant Ranking